Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about GARS1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Glycyl-tRNA synthetase 1 - essential for protein synthesis, mutations cause Charcot-Marie-Tooth disease type 2D
No AI portrait yet
| Gene Symbol | GARS1 |
| Aliases | Glycyl-tRNA synthetase 1 |
| Protein Type | Synthetase |
| Function | The enzymatic reaction proceeds through a two-step mechanism |
| Ensembl ID | ENSG00000106105 |
| GeneCards | GARS1 |
| Human Protein Atlas | GARS1 |
| N-terminal domain | Involved in dimerization and protein-protein interactions |
| Catalytic domain | Contains the active site for amino acid activation and tRNA binding |
| C-terminal domain | Contributes to tRNA recognition and editing function |
| Editing domain | Prevents mischarging of tRNA with incorrect amino acids (proofreading) |
| RNA splicing | Associates with spliceosome components |
| Cell signaling | Modulates MAPK/ERK and PI3K/AKT pathways |
| Immune regulation | Involved in interferon-responsive gene expression |
| Angiogenesis | Promotes blood vessel formation through VEGF signaling |
| Associated Diseases | neurodegeneration |
| KG Connections | 1 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
N0["GARS1"]
N1["BDNF"]
N1 -->|"co expressed with"| N0
N2["neurodegeneration"]
N0 -->|"implicated in"| N2
classDef gene fill:#1a3a2a,stroke:#4caf50,color:#e0e0e0
classDef protein fill:#1a2a3a,stroke:#4fc3f7,color:#e0e0e0
classDef disease fill:#3a1a1a,stroke:#ef5350,color:#e0e0e0
classDef pathway fill:#2a1a3a,stroke:#ce93d8,color:#e0e0e0
classDef mechanism fill:#2a2a1a,stroke:#ffd54f,color:#e0e0e0
class N1 gene| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| BDNF | co_expressed_with | gene | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning GARS1 in their description or question text
No additional research found